Skip to main content
. 2011 Nov 30;13(2):121–127. doi: 10.1007/s10194-011-0405-6

Table 1.

Medications for migraine and depression used by participants

Antimigraine medications Antidepressants
Acetaminophen/caffeine/isometheptene mucate Alprazolam
Acetaminophen/dichloralphenazone/isometheptene mucate Alprazolam extended-release
Almotriptan malate Amitriptyline hydrochloride
Dihydroergotamine mesylate Amitriptyline-chlordiazepoxide
Eletriptan hydrobromide Budeprion hydrochloride
Ergotamine-caffeine Budeprion hydrochloride extended-release
Frovatriptan succinate Budeprion hydrochloride sustained-release
Naratriptan hydrochloride Citalopram hydrobromide
Rizatriptan benzoate Clomipramine hydrochloride
Sumatriptan succinate Clorazepate dipotassium
Sumatriptan succinate/naproxen sodium Desipramine hydrochloride
Zolmitriptan Desvenlafaxine succinate
Diazepam
Doxepin hydrochloride
Duloxetine hydrochloride
Escitalopram oxalate
Fluoxetine hydrochloride
Fluoxetine hydrochloride/olanzapine
Fluoxetine pamoate
Imipramine hydrochloride
Lorazepam
Mirtazapine
Nortriptyline hydrochloride
Oxazepam
Paroxetine hydrochloride
Paroxetine mesylate
Phenelzine sulfate
Trazodone hydrochloride
Venlafaxine hydrochloride
Venlafaxine hydrochloride extended-release